
Acelyrin (SLRN) Stock Surges After Unsolicited Buyout Proposal
Shares of Acelyrin, Inc. (NASDAQ: SLRN) increased 12.44% to $2.44 on Thursday after an equity-related development was confirmed. An unsolicited takeover offer from Concentra Biosciences,